Institutional Manager · CIK 0000882095
GILEAD SCIENCES, INC.
FOSTER CITY, CA · File #028-25078
Latest AUM
$1.94B
Positions
6
Top-10 Concentration
100.0%
Filings
5
Portfolio Value Over Time
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | MERUS N V | N5749R100 | -452,527 | -$42.6M | $0 |
| EXITED | TANGO THERAPEUTICS INC | 87583X109 | -4,854,443 | -$40.8M | $0 |
| EXITED | LEAP THERAPEUTICS INC | 52187K200 | -5,319,148 | -$2.4M | $0 |
| REDUCE | ARCELLX INC | ACLX | 0 | $0 | -$113.6M |
| REDUCE | ARCUS BIOSCIENCES INC | RCUS | 0 | $0 | +$321.5M |
| REDUCE | ASSEMBLY BIOSCIENCES INC | ASMB | 0 | $0 | +$37.9M |
| REDUCE | GALAPAGOS NV | GLPGF | 0 | $0 | -$28.1M |
| REDUCE | KYVERNA THERAPEUTICS INC | KYTX | 0 | $0 | +$14.0M |
| REDUCE | XILIO THERAPEUTICS INC | XLO | 0 | $0 | -$1.8M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20256 pos · $1.94B
- 13F HOLDINGS REPORTQ/E Sep 20259 pos · $1.79B
- 13F HOLDINGS REPORTQ/E Jun 202514 pos · $1.28B
- 13F HOLDINGS REPORTQ/E Mar 202514 pos · $1.18B
- 13F HOLDINGS REPORTQ/E Dec 202416 pos · $1.55B
Top 6 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ARCUS BIOSCIENCES INC | RCUS | 31,424,760 | $748.9M | 38.69% |
| 2 | GALAPAGOS NV | GLPGF | 16,707,477 | $550.6M | 28.45% |
| 3 | ARCELLX INC | ACLX | 6,720,803 | $438.2M | 22.64% |
| 4 | ASSEMBLY BIOSCIENCES INC | ASMB | 4,505,391 | $153.2M | 7.92% |
| 5 | KYVERNA THERAPEUTICS INC | KYTX | 4,126,119 | $38.8M | 2.00% |
| 6 | XILIO THERAPEUTICS INC | XLO | 9,105,451 | $5.8M | 0.30% |